MX2021009055A - Pauta posológica y método para tratar la hipertensión arterial pulmonar con rodatristat etilo. - Google Patents

Pauta posológica y método para tratar la hipertensión arterial pulmonar con rodatristat etilo.

Info

Publication number
MX2021009055A
MX2021009055A MX2021009055A MX2021009055A MX2021009055A MX 2021009055 A MX2021009055 A MX 2021009055A MX 2021009055 A MX2021009055 A MX 2021009055A MX 2021009055 A MX2021009055 A MX 2021009055A MX 2021009055 A MX2021009055 A MX 2021009055A
Authority
MX
Mexico
Prior art keywords
arterial hypertension
pulmonary arterial
treating pulmonary
ethyl
rodatristat
Prior art date
Application number
MX2021009055A
Other languages
English (en)
Spanish (es)
Inventor
Michelle Palacios
Eric J Gaukel
Stephen A Wring
Magdalena Alonso-Galicia
Original Assignee
Altavant Sciences Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altavant Sciences Gmbh filed Critical Altavant Sciences Gmbh
Publication of MX2021009055A publication Critical patent/MX2021009055A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2021009055A 2019-01-30 2020-01-30 Pauta posológica y método para tratar la hipertensión arterial pulmonar con rodatristat etilo. MX2021009055A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962798827P 2019-01-30 2019-01-30
PCT/IB2020/000074 WO2020157577A1 (en) 2019-01-30 2020-01-30 A dosage regime and method for treating pulmonary arterial hypertension with rodatristat ethyl

Publications (1)

Publication Number Publication Date
MX2021009055A true MX2021009055A (es) 2021-10-22

Family

ID=70285725

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021009055A MX2021009055A (es) 2019-01-30 2020-01-30 Pauta posológica y método para tratar la hipertensión arterial pulmonar con rodatristat etilo.

Country Status (9)

Country Link
US (2) US11607413B2 (cg-RX-API-DMAC7.html)
EP (1) EP3917531A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022518944A (cg-RX-API-DMAC7.html)
KR (1) KR20210133953A (cg-RX-API-DMAC7.html)
CN (1) CN113557022A (cg-RX-API-DMAC7.html)
AU (1) AU2020213746A1 (cg-RX-API-DMAC7.html)
CA (1) CA3128327A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021009055A (cg-RX-API-DMAC7.html)
WO (1) WO2020157577A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210102887A (ko) * 2018-11-14 2021-08-20 알타반트 사이언시스 게엠베하 말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제
AU2019382168A1 (en) 2018-11-16 2021-06-03 Altavant Sciences Gmbh A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension
WO2020128614A1 (en) * 2018-12-17 2020-06-25 Altavant Sciences Gmbh Method for treating interstital lung disease
CN113557022A (zh) 2019-01-30 2021-10-26 阿尔塔万特科学公司 用罗达司他乙酯治疗肺动脉高压的给药方案和方法
CN113784717A (zh) * 2019-03-15 2021-12-10 阿尔塔万特科学公司 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药
WO2023062595A1 (en) 2021-10-14 2023-04-20 Altavant Sciences Gmbh Treatment of subjects having pulmonary arterial hypertension with rodatristat ethyl

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101815534A (zh) 2007-07-11 2010-08-25 莱西肯医药有限公司 用于治疗肺动脉高压以及相关疾病和病症的方法和组合物
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
KR20210102887A (ko) 2018-11-14 2021-08-20 알타반트 사이언시스 게엠베하 말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제
AU2019382168A1 (en) 2018-11-16 2021-06-03 Altavant Sciences Gmbh A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension
US20200188398A1 (en) 2018-12-17 2020-06-18 Altavant Sciences Gmbh Method for treating sarcoidosis-associated pulmonary hypertension
WO2020128614A1 (en) 2018-12-17 2020-06-25 Altavant Sciences Gmbh Method for treating interstital lung disease
CN113557022A (zh) 2019-01-30 2021-10-26 阿尔塔万特科学公司 用罗达司他乙酯治疗肺动脉高压的给药方案和方法
CN113784717A (zh) * 2019-03-15 2021-12-10 阿尔塔万特科学公司 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药

Also Published As

Publication number Publication date
WO2020157577A8 (en) 2020-10-15
CA3128327A1 (en) 2020-08-06
US20200237759A1 (en) 2020-07-30
JP2022518944A (ja) 2022-03-17
US20240041877A1 (en) 2024-02-08
WO2020157577A1 (en) 2020-08-06
CN113557022A (zh) 2021-10-26
AU2020213746A1 (en) 2021-08-19
KR20210133953A (ko) 2021-11-08
EP3917531A1 (en) 2021-12-08
US11607413B2 (en) 2023-03-21

Similar Documents

Publication Publication Date Title
WO2020157577A8 (en) A dosage regime and method for treating pulmonary arterial hypertension with rodatristat ethyl
US8278300B2 (en) Use for PDE5 inhibitors
US20080102137A1 (en) Composition and method for etiological treatment and prevention of diseases and/or complications associated with chronic glucose metabolism destabilization
MX2021011224A (es) Un método para tratar la hipertensión arterial pulmonar y la hipertensión arterial pulmonar asociada y pauta posológica diaria.
US9937195B2 (en) Edible energy composition
WO1998037883A1 (en) Forskohlin for promoting lean body mass
WO2007129161A3 (en) Thieno [3, 2-d] pyrimidine derivative useful as pi3k inhibitor
FI3801536T3 (fi) Sepiapteriinin antaminen ilman ruokaa käytettäväksi menetelmässä sepiapteriinin plasma-altistuksen lisäämiseksi
US20170274002A1 (en) Multiple folate formulation and use thereof
US20250319041A1 (en) Compositions comprising Quinone and/or Quinol and methods of preparations and use thereof
JP2022518944A5 (cg-RX-API-DMAC7.html)
US20200155552A1 (en) Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension
US12194042B2 (en) Uses
US20210121469A1 (en) Edible Energy Composition
WO1993010787A1 (en) Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone
US5217974A (en) Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
CN1705476A (zh) 酒精代谢的增强
JPH085791B2 (ja) 抗白内障剤
CN110101849B (zh) 一种酶催化解酒作用的组合物及其制备方法与应用
Kovach et al. Contribution of adenosine to the regulation of cerebral blood flow: the role of calcium ions in the adenosine-induced cerebrocortical vasodilatation
CA1181694A (fr) Compositions pharmaceutiques contenant de l'almitrine
EP0505640B1 (en) Improved therapeutic method
RU2010148158A (ru) Способ диагностики и коррекции эндотелиальной дисфункции сосудистых осложнений сахарного диабета в эксперименте
TH2101001610A (th) สารประกอบการกระตุ้นไพรูเวทไคเนสอาร์ (pkr)
Colombo et al. Suppression of ethanol intake in ethanol-preferring rats by 1, 4-butanediol